ArticleFrontiers in public health2025
Epidemiological and molecular analysis of anthrax cases of the Zhambyl region Kazakhstan in 2023.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of Nanopore amplicon sequencing method for culture-free genotyping ofFrontiers in microbiology · 2026Article
- Severe cutaneous anthrax with systemic complications: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anthrax, caused by Objective: This study aimed to characterize the epidemiological, clinical, and molecular features of human anthrax cases reported in the Zhambyl region of Kazakhstan during 2023. Methods: A total of 41 suspected cases were investigated, of which 19 were confirmed by culture and PCR (targeting pXO1 and pXO2). Data collection included patient demographics, exposure circumstances, clinical manifestations, and laboratory diagnostics. MLVA-31 genotyping was used to characterize Results: Confirmed cases were clustered in five district localities, yielding an incidence rate of 1.55 per 100,000 population. The majority of patients were male (84.2%), with exposure primarily linked to slaughter activities (68.4%). Culture was successful in 12 of 19 confirmed cases, and all isolates were susceptible to a broad range of antibiotics, including ciprofloxacin and doxycycline. Genotyping revealed three distinct clusters: one matching the A.Br.001/002 genotype common to northeastern China and Mongolia, and two divergent clusters likely represent localized evolution of Conclusion: The 2023 outbreak of anthrax in the Zhambyl region highlights the ongoing risk posed by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.